Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Natures Miracle Holding | NMHI | 27. nov 2024 | 2.81 | +16.12 |
Natures Sunshine Products | NATR | 27. nov 2024 | 16.15 | -1.94 |
Natuzzi ADR | NTZ | 27. nov 2024 | 4.70 | -3.29 |
NatWest ADR | NWG | 27. nov 2024 | 10.03 | +1.01 |
Nauticus Robotics | KITT | 27. nov 2024 | 1.12 | +9.80 |
Nautilus Biotechnology | NAUT | 27. nov 2024 | 2.30 | +2.68 |
Navidea Biopharmaceuticals | NAVB | 27. nov 2024 | 0.00 | 0.00 |
Navient | NAVI | 27. nov 2024 | 15.32 | +0.46 |
Navigator Holdings | NVGS | 27. nov 2024 | 15.72 | +0.51 |
Navios Maritime Partners LP Unit | NMM | 27. nov 2024 | 47.91 | +0.67 |
Navitas Semiconductor | NVTS | 27. nov 2024 | 2.46 | -3.53 |
Naya Biosciences | NAYA | 27. nov 2024 | 0.94 | 0.00 |
Nayax | NYAX | 27. nov 2024 | 29.74 | +2.16 |
NB Bancorp | NBBK | 27. nov 2024 | 20.18 | -0.54 |
NBT Bancorp | NBTB | 27. nov 2024 | 50.08 | -0.08 |
Ncino | NCNO | 27. nov 2024 | 41.88 | -0.88 |
NCR | VYX | 27. nov 2024 | 14.49 | +0.98 |
NCR Atleos When Issued | NATL | 27. nov 2024 | 32.68 | +1.59 |
NCS Multistage | NCSM | 27. nov 2024 | 22.56 | -0.31 |
Nebius Group | NBIS | 27. nov 2024 | 21.43 | 0.00 |
Nektar Therapeutics | NKTR | 27. nov 2024 | 1.13 | +5.61 |
Nelnet | NNI | 27. nov 2024 | 108.76 | -0.23 |
Neogen | NEOG | 27. nov 2024 | 14.14 | -0.21 |
NeoGenomics | NEO | 27. nov 2024 | 17.74 | +3.26 |
Neonode | NEON | 27. nov 2024 | 7.85 | +1.29 |
NeoVolta | NEOV | 27. nov 2024 | 4.96 | -8.66 |
Nephros | NEPH | 27. nov 2024 | 1.51 | -3.21 |
NerdWallet A | NRDS | 27. nov 2024 | 14.23 | +2.60 |
Nerdy A | NRDY | 27. nov 2024 | 1.38 | -6.12 |
Net Lease Office Properties When Issued | NLOP | 27. nov 2024 | 32.12 | +2.49 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.